血栓除去デバイス - 世界市場の考察、競合情勢、市場予測（2030年）

世界の血栓除去デバイスの市場規模は、2024年～2030年の予測期間にCAGRで5.24％の大幅な成長が見込まれます。血栓除去デバイスの需要は、低血圧、糖尿病、肥満、加齢などの生活習慣病の有病率の増加によって後押しされています。さらに、静脈血栓塞栓症や心血管疾患、がん、そして虚血性脳卒中や出血性脳卒中、末梢疾患などの神経疾患などの有病率の増加は、血栓の形成につながり、血栓除去デバイスの需要の増加につながります。加えて、治療に向けた低侵襲アプローチに対する需要の増加や、運動不足、喫煙の増加、デバイスの発売と承認の増加、製品開発における技術革新の急増、先進技術を利用した製品の開発や、神経血管疾患とその予防に関する認識を高める取り組みへの主要企業の注目のシフトなどが、2024年～2030年の予測期間における血栓除去デバイス市場の全体的な成長に寄与しています。

血栓除去デバイスの市場力学

血栓除去デバイス市場はさまざまな要因によって製品需要が伸びており、主な要因の1つは静脈血栓塞栓症の有病率の増加です。

例えば、米国疾病予防管理センター（CDC）（2023）によると、米国では毎年約90万人が深部静脈血栓症（DVT）または肺塞栓症（PE）に罹患すると推定されています。さらに、静脈血栓症（DVT）または肺塞栓症（PE）に罹患した人の3分の1～2分の1近くが、患肢の腫脹、疼痛、変色、鱗屑などの長期合併症（血栓後症候群）を有する可能性があります。

Thrombosis UK（2023）は、欧米では37秒に1人の割合で静脈血栓塞栓症（VTE）が原因で死亡していると述べています。また、VTE症例の55～60％近くが入院中または入院後に発症しています。したがって、静脈血栓塞栓症の有病率の増加は、血栓除去デバイスのような静脈血栓塞栓症の治療に使用されるデバイスの需要を増加させ、それによって市場全体の成長を促進します。

神経血栓除去デバイスは、高齢者によく見られる脳卒中の現象である虚血性脳卒中の治療に不可欠です。脳卒中は高齢者の身体障害の主因の1つであり、脳卒中発症後に身体的な介助やサポートを必要とする患者は全体の約65%に上ります。World Stroke Organization（2023）によると、世界全体では25歳以上の成人の4人に1人が一生のうちに脳卒中を発症し、1億1,000万人以上が脳卒中を経験しています。世界保健機関（WHO）（2023）の推計によると、世界中で年間1,500万人が脳卒中に罹患し、そのうち500万人が死亡し、さらに500万人が後遺症を残し、家族や地域社会に負担をかけています。神経血栓除去は患者の機能的転帰を向上させ死亡率を低下させるため、急性虚血性脳卒中に対するもっとも好ましい治療法です。

したがって、脳卒中の有病率の増加は、市場における血栓除去デバイスの需要を増加させます。

虚血性脳卒中の罹患率の上昇により、市場に最先端の商品を導入する必要性が生まれています。虚血性脳卒中関連の新しい吸引デバイス、血栓回収デバイス、吸引カテーテルの開発と導入が市場を牽引しています。例えば、急性虚血性脳卒中に対する手技を進歩させるため、Phenox GmbHは2021年にpRESET 6-50機械的血栓除去デバイスを世界中で発売しました。

また、2022年4月にはPenumbraがLightning 7およびLightning 12機械的血栓除去技術を搭載したIndigo Aspiration SystemのCEマークを取得しました。この2つの技術は、肺塞栓症治療を含む末梢動脈系と静脈系の血栓を1回で除去するために設計されています。

したがって、上記の要因が2024年～2030年の予測期間における血栓除去デバイス市場の成長に寄与しています。

しかし、デバイス関連の合併症や厳しい規制シナリオなどが、今後数年間の血栓除去デバイス市場の成長を抑制する可能性があります。

当レポートでは、世界の血栓除去デバイス市場について調査分析し、市場規模と予測、促進要因と課題、企業と製品のプロファイルなどを提供しています。

目次

第1章 血栓除去デバイス市場レポートのイントロダクション

第2章 血栓除去デバイス市場のエグゼクティブサマリー

• 調査範囲
• 市場の概要
• 競合の評価

第3章 規制分析

• 米国
• 欧州
• 日本
• 中国

第4章 血栓除去デバイス市場の主な要因の分析

• 血栓除去デバイス市場の促進要因
• 血栓除去デバイス市場の抑制要因と課題
• 血栓除去デバイス市場の機会

第5章 血栓除去デバイス市場のポーターのファイブフォース分析

第6章 血栓除去デバイスの市場レイアウト

• 製品別
  • 吸引血栓除去デバイス
  • 機械的血栓除去デバイス
  • 超音波血栓除去デバイス
  • その他
• 用途別
  • 心血管血栓除去
  • 神経血管血栓除去
  • 末梢血管血栓除去
• エンドユーザー別
  • 病院・診療所
  • 外来手術センター
• 地域
  • 北米
  • 欧州
  • アジア太平洋
  • その他の地域

第7章 血栓除去デバイス市場の企業と製品のプロファイル

• Koninklijke Philips N.V.
• Terumo Corporation
• Medtronic
• Boston Scientific Corporation
• Penumbra, Inc.
• Thrombolex
• Imperative Care Inc.
• Stryker
• Argon Medical Devices Inc.
• Edwards Lifesciences Corporation
• Johnson & Johnson
• BD
• phenox GmbH
• DSMAREF CO.LTD
• Teleflex Incorporated
• AngioDynamics
• Abbott
• inari medical
• Merit Medical Systems
• Acandis GmbH

第8章 KOLの見解

第9章 プロジェクトアプローチ

第10章 DelveInsightのサービス内容

第11章 DelveInsightについて

第12章 免責事項、お問い合わせ

List of Tables

• Table 1: Competitive Analysis
• Table 2: Thrombectomy Devices Market in Global (2021-2030)
• Table 3: Thrombectomy Devices Market in Global by Product (2021-2030)
• Table 4: Thrombectomy Devices Market in Global by Application (2021-2030)
• Table 5: Thrombectomy Devices Market in Global by End-User (2021-2030)
• Table 6: Thrombectomy Devices Market in Global by Geography (2021-2030)
• Table 7: Thrombectomy Devices Market in North America (2021-2030)
• Table 8: Thrombectomy Devices Market in the US (2021-2030)
• Table 9: Thrombectomy Devices Market in Canada (2021-2030)
• Table 10: Thrombectomy Devices Market in Mexico (2021-2030)
• Table 11: Thrombectomy Devices Market in Europe (2021-2030)
• Table 12: Thrombectomy Devices Market in France (2021-2030)
• Table 13: Thrombectomy Devices Market in Germany (2021-2030)
• Table 14: Thrombectomy Devices Market in the United Kingdom (2021-2030)
• Table 15: Thrombectomy Devices Market in Italy (2021-2030)
• Table 16: Thrombectomy Devices Market in Spain (2021-2030)
• Table 17: Thrombectomy Devices Market in the Rest of Europe (2021-2030)
• Table 18: Thrombectomy Devices Market in Asia-Pacific (2021-2030)
• Table 19: Thrombectomy Devices Market in China (2021-2030)
• Table 20: Thrombectomy Devices Market in Japan (2021-2030)
• Table 21: Thrombectomy Devices Market in India (2021-2030)
• Table 22: Thrombectomy Devices Market in Australia (2021-2030)
• Table 23: Thrombectomy Devices Market in South Korea (2021-2030)
• Table 24: Thrombectomy Devices Market in Rest of Asia-Pacific (2021-2030)
• Table 25: Thrombectomy Devices Market in the Rest of the World (2021-2030)
• Table 26: Thrombectomy Devices Market in the Middle East (2021-2030)
• Table 27: Thrombectomy Devices Market in Africa (2021-2030)
• Table 28: Thrombectomy Devices Market in South America (2021-2030)

List of Figures

• Figure 1: Competitive Analysis
• Figure 2: Thrombectomy Devices Market in Global (2021-2030)
• Figure 3: Thrombectomy Devices Market in Global by Product (2021-2030)
• Figure 4: Thrombectomy Devices Market in Global by Application (2021-2030)
• Figure 5: Thrombectomy Devices Market in Global by End-User (2021-2030)
• Figure 6: Thrombectomy Devices Market in Global by Geography (2021-2030)
• Figure 7: Thrombectomy Devices Market in North America (2021-2030)
• Figure 8: Thrombectomy Devices Market in the US (2021-2030)
• Figure 9: Thrombectomy Devices Market in Canada (2021-2030)
• Figure 10: Thrombectomy Devices Market in Mexico (2021-2030)
• Figure 11: Thrombectomy Devices Market in Europe (2021-2030)
• Figure 12: Thrombectomy Devices Market in France (2021-2030)
• Figure 13: Thrombectomy Devices Market in Germany (2021-2030)
• Figure 14: Thrombectomy Devices Market in the United Kingdom (2021-2030)
• Figure 15: Thrombectomy Devices Market in Italy (2021-2030)
• Figure 16: Thrombectomy Devices Market in Spain (2021-2030)
• Figure 17: Thrombectomy Devices Market in the Rest of Europe (2021-2030)
• Figure 18: Thrombectomy Devices Market in Asia-Pacific (2021-2030)
• Figure 19: Thrombectomy Devices Market in China (2021-2030)
• Figure 20: Thrombectomy Devices Market in Japan (2021-2030)
• Figure 21: Thrombectomy Devices Market in India (2021-2030)
• Figure 22: Thrombectomy Devices Market in Australia (2021-2030)
• Figure 23: Thrombectomy Devices Market in South Korea (2021-2030)
• Figure 24: Thrombectomy Devices Market in Rest of Asia-Pacific (2021-2030)
• Figure 25: Thrombectomy Devices Market in the Rest of the World (2021-2030)
• Figure 26: Thrombectomy Devices Market in the Middle East (2021-2030)
• Figure 27: Thrombectomy Devices Market in Africa (2021-2030)
• Figure 28: Thrombectomy Devices Market in South America (2021-2030)
• Figure 29: Market Drivers
• Figure 30: Market Barriers
• Figure 31: Marker Opportunities
• Figure 32: PORTER'S Five Force Analysis

Thrombectomy Devices Market By Product (Aspiration Thrombectomy Devices, Mechanical Thrombectomy Devices, Ultrasonic Thrombectomy Devices, And Others), Application (Cardiovascular Thrombectomy, Neurovascular Thrombectomy, And Peripheral Vascular Thrombectomy), End-User (Hospitals & Clinics, Ambulatory Surgical Centers, And Others), and geography is expected to grow at a steady CAGR forecast till 2030 owing to the increasing cases of blood clots owing to rising prevalence of various cardiovascular and neurological diseases and the growing figures of various risk factors such as obesity, age, and others

The global thrombectomy devices market is poised for significant growth, projected to achieve a remarkable Compound Annual Growth Rate (CAGR) of 5.24% during the forecast period from 2024 to 2030. The demand for thrombectomy devices is being boosted by the increasing prevalence of lifestyle disorders such as low blood pressure, diabetes, obesity, age, and others. Further, the increasing prevalence of venous thromboembolism, cardiovascular diseases, cancer, and neurological diseases such as ischemic stroke, hemorrhagic stroke, and peripheral diseases, among others will lead to the formation of blood clots, thereby leading to the increased demand for thrombectomy devices. In addition, the increasing demand for minimally invasive approaches for treatment, lack of physical activity, rising adoption of smoking, rising device launches and approvals, surging innovations in product development, and shifting key players' focus towards the development of technologically advanced product and initiatives to increase awareness regarding neurovascular diseases and their prevention among others are thereby contributing to the overall growth of the thrombectomy devices market during the forecast period from 2024-2030.

Thrombectomy Devices Market Dynamics:

The thrombectomy devices market is witnessing a growth in product demand owing to various factors, one of the key factors being the increase in the prevalence of venous thromboembolism.

For instance, as per the Centers for Disease Control and Prevention (CDC) 2023, it was estimated that approximately 900,000 people could be affected by deep vein thrombosis (DVT) or pulmonary embolism (PE) each year in the United States. Further, nearly one-third to one-half of people suffering from vein thrombosis (DVT) or pulmonary embolism (PE) may have long-term complications (post-thrombotic syndrome) such as swelling, pain, discoloration, and scaling in the affected limb.

Thrombosis UK (2023), stated that every 37 seconds someone in the Western world dies from venous thromboembolism (VTE). Also, nearly 55 to 60 percent of VTE cases occur during or following hospitalization. Thus, the increasing prevalence of venous thromboembolism will increase the demand for devices used in the treatment of venous thromboembolism such as thrombectomy devices, thereby propelling the overall market growth.

Neurothrombectomy devices are critical in treating ischemic stroke, a commonly occurring phenomenon of stroke among older adults. Stroke is one of the leading causes of disability among the elderly with around 65% of patients requiring physical assistance or support post an episode of stroke. As per the source, World Stroke Organization 2023, stated that globally 1 in 4 adults over the age of 25 will have a stroke in their lifetime and over 110 million people in the world have experienced stroke. The World Health Organization (WHO) 2023, estimated that annually, 15 million people worldwide suffer a stroke and of these, 5 million die, and another 5 million are left permanently disabled, placing a burden on family and community. Since the neurothrombectomy procedure improves functional outcomes and lowers the mortality rate in patients, therefore, it is the most preferred treatment for acute ischemic stroke.

Thus, the increasing prevalence of stroke will increase the demand for thrombectomy devices in the market.

The need to introduce cutting-edge items to the market has been brought on by the rise in ischemic stroke incidence. The market is driven by the development and introduction of new ischemic stroke-related suction devices, clot retrievers, and aspiration catheters. For instance, to advance its technique for acute ischemic stroke, Phenox GmbH launched pRESET 6-50 mechanically thrombectomy devices globally in 2021.

Also, in April 2022, Penumbra obtained a CE Mark for its Indigo Aspiration System with Lightning 7 and Lightning 12 mechanical thrombectomy technologies. The two technologies are designed for the removal of single-session blood clot in peripheral arterial and venous systems, including the pulmonary embolisms treatment.

Therefore, the above-mentioned factors are contributing to the growth of the thrombectomy devices market during the forecast period from 2024-2030.

However, device-related complications, stringent regulatory scenarios, and others may restrict the thrombectomy devices market growth in the upcoming years.

Thrombectomy Devices Market Segment Analysis:

Thrombectomy Devices Market by Product (Aspiration Thrombectomy Devices, Mechanical Thrombectomy Devices, Ultrasonic Thrombectomy Devices, and Others), Application (Cardiovascular Thrombectomy, Neurovascular Thrombectomy, and Peripheral Vascular Thrombectomy), End-User (Hospitals & Clinics, Ambulatory Surgical Centers, and Others), and Geography (North America, Europe, Asia-Pacific, Rest of the World)

In the product segment of the thrombectomy devices market, the mechanical thrombectomy category is expected to amass a significant revenue share in the year 2023. This can be ascribed to the applications and advantages related to the segment.

Mechanical thrombectomy is a type of minimally invasive procedure in which an interventional radiologist uses specialized equipment to remove a clot from a patient's artery. It is a new technique of stroke treatment that eliminates blood clots from the brain's major blood arteries. Patients who experienced an acute ischemic stroke brought on by a significant artery blockage in the anterior circulation of the brain are advised to undergo the mechanical thrombectomy procedure.

When combined with a type of systemic thrombolytic agent and other medical procedures, mechanical thrombectomy greatly reduces the number of patients who experience stroke-related impairments. During the forecast period, demand for mechanical thrombectomy devices is anticipated to increase due to the rise in demand for less invasive surgical procedures and favorable reimbursement policies for cardiovascular and neurovascular operations.

Furthermore, various companies are conducting research and development related to mechanical thrombectomy devices to increase their product portfolio. For instance, in May 2023, Akura Medical, a Shifamed portfolio company initiated its first-in-human clinical study of the Akura Mechanical Thrombectomy Platform. The Akura platform is a low-profile solution designed to easily access and efficiently remove large volume, mixed morphology clots, and eliminate the guesswork around the procedure.

Also, in July 2021, Surmodics, Inc., acquired privately held Vetex Medical Limited, an Ireland-based medical device developer and manufacturer. The transaction expands Surmodics' thrombectomy portfolio with a second U.S. Food and Drug Administration (FDA) 510(k)-cleared device, the ReVene(TM) Thrombectomy Catheter. The ReVene mechanical thrombectomy catheter is designed to remove large, mixed-morphology blood clots commonly found with venous thromboembolism (VTE).

Therefore, the advantages offered by mechanical thrombectomy are predicted to contribute to the increasing demand for this product, thereby driving the growth of the overall thrombectomy devices market during the forecast period.

North America is expected to dominate the overall Thrombectomy Devices Market:

Among all the regions, North America is estimated to account for the largest share of the thrombectomy devices market in the year 2023. Owing to the significance of key growth factors including the rising prevalence of cancers, neurological diseases, cardiovascular diseases, venous thromboembolism, and others, the rising burden of the geriatric population base prone to afore-said diseases, the increasing number of obese people, early adoption of new technologies, innovative technologies and infrastructure resulting in significant healthcare facilities and patient care, increase in investments by government & private institutions, and escalating regulatory approvals among others, the North America thrombectomy devices market is expected to witness positive growth.

For instance, as per CDC 2023, one-third (about 33%) of people suffering from deep vein thrombosis (DVT) or pulmonary embolism (PE) in the US will have a recurrence of the disease within 10 years.

According to the CDC 2021 report, every year, more than 795,000 people in the United States have a stroke and about 610,000 of these are first or new strokes. In addition, the report also stated that 87% of all strokes are ischemic strokes, in which blood flow to the brain is blocked.

The above sources, clearly indicate that the prevalence of cardiovascular diseases and neurological diseases is surging in the region, ultimately increasing the demand for thrombectomy devices which are used for the management or treatment of the aforementioned diseases.

Coupled with the factors mentioned above, the increasing regulatory approvals and launches in the region will also drive the market of thrombectomy devices. For instance, in August 2021, Stryker Neurovascular received the US FDA approval for their Trevo NXT Pro Vue Retriever, a class II medical device classified as a neurovascular mechanical thrombectomy device for acute ischemic stroke.

Also, in February 2020, Stryker received the US FDA approval for Trevo NXT ProVue Retriever indicated for use to restore blood flow in the neurovasculature by removing thrombus for the treatment of acute ischemic stroke.

Thus, such strategic steps help to increase the demand for thrombectomy devices, thereby driving the North America thrombectomy devices market forward during the forecast period.

Thrombectomy Devices Market Key Players:

Some of the key market players operating in the thrombectomy devices market include Koninklijke Philips N.V., Terumo Corporation, Medtronic, Boston Scientific Corporation, Penumbra, Inc., Thrombolex, Imperative Care Inc., Stryker, Argon Medical Devices Inc., Edwards Lifesciences Corporation, Johnson & Johnson, BD, phenox GmbH, DSMAREF CO.LTD, Teleflex Incorporated, AngioDynamics, Abbott, inari medical, Merit Medical Systems, Acandis GmbH, and others.

Recent Developmental Activities in the Thrombectomy Devices Market:

• In September 2022, Vesalio announced European CE Mark approval of the company's NeVa Net thrombectomy device, which features integrated clot microfiltration technology.
• In September 2021, Abbott acquired Walk Vascular, LLC, a commercial-stage medical device company with a minimally invasive mechanical aspiration thrombectomy system designed to remove peripheral blood clots. Walk Vascular's peripheral thrombectomy systems will be incorporated into Abbott's existing endovascular product portfolio.
• In May 2020, Control Medical Technology obtained the US Food and Drug Administration (FDA) approval for its Aspire MAX 7 - 11F Mechanical Thrombectomy platform. Aspire MAX 7 - 11F Mechanical Thrombectomy platform has been designed to remove blood clots from the peripheral vessels.

Key Takeaways from the Thrombectomy Devices Market Report Study

• Market size analysis for current thrombectomy devices market size (2023), and market forecast for 6 years (2024-2030)
• Top key product/services/technology developments, mergers, acquisitions, partnerships, and joint ventures happened for the last 3 years
• Key companies dominating the global thrombectomy devices market
• Various opportunities are available for the other competitors in the thrombectomy devices market space.
• What are the top-performing segments in 2023? How these segments will perform in 2030?
• Which are the top-performing regions and countries in the current thrombectomy devices market scenario?
• Which are the regions and countries where companies should have concentrated on opportunities for thrombectomy devices market growth in the coming future?

Target Audience who can be benefited from this Thrombectomy Devices Market Report Study

• Thrombectomy devices providers
• Research organizations and consulting companies
• Thrombectomy devices -related organizations, associations, forums, and other alliances
• Government and corporate offices
• Start-up companies, venture capitalists, and private equity firms
• Distributors and Traders dealing in thrombectomy devices
• Various End-users who want to know more about the thrombectomy devices market and the latest technological developments in the thrombectomy devices market.

Frequently Asked Questions for the Thrombectomy Devices Market:

1. What are thrombectomy devices?

Thrombectomy is an interventional procedure performed to remove clots from a blood vessel. It is commonly performed in coronary arteries, peripheral arteries, and cerebral arteries.

2. What is the market for global thrombectomy devices?

The global thrombectomy devices market is poised for significant growth, projected to achieve a remarkable Compound Annual Growth Rate (CAGR) of 5.24% during the forecast period from 2024 to 2030.

3. What are the drivers for the global thrombectomy devices market?

The demand for thrombectomy devices is primarily being heightened by the rising cases of cardiovascular diseases and cancers, the growing prevalence of neurological disorders such as acute ischemic stroke, and hemohragic stroke, the rising number of obese and geriatric population, rising product launches and approvals, along with a growing number of research and development activities, thereby contributing to the overall growth of thrombectomy devices market during the forecast period from 2024-2030.

4. Who are the key players operating in the global thrombectomy devices market?

Some of the key market players operating in the thrombectomy devices market include Koninklijke Philips N.V., Terumo Corporation, Medtronic, Boston Scientific Corporation, Penumbra, Inc., Thrombolex, Imperative Care Inc., Stryker, Argon Medical Devices Inc., Edwards Lifesciences Corporation, Johnson & Johnson, BD, phenox GmbH, DSMAREF CO.LTD, Teleflex Incorporated, AngioDynamics, Abbott, inari medical, Merit Medical Systems, Acandis GmbH, and others.

5. Which region has the highest share in the thrombectomy devices market?

North America is expected to dominate the overall thrombectomy devices market during the forecast period from 2024-2030.

Factors such as the rising prevalence of venous thromboembolism, cardiovascular diseases, neurovascular, and peripheral diseases, among others, the rising geriatric population, technological advancements in medical devices used for capturing blood clots, the presence of key players in the region, and the escalating regulatory approvals are said to drive the growth of North America thrombectomy devices market.

Table of Contents

1. Thrombectomy Devices Market Report Introduction

2. Thrombectomy Devices Market Executive Summary

• 2.1. Scope of the Study
• 2.2. Market at Glance
• 2.3. Competitive Assessment

3. Regulatory Analysis

• 3.1. The United States
• 3.2. Europe
• 3.3. Japan
• 3.4. China

4. Thrombectomy Devices Market Key Factors Analysis

• 4.1. Thrombectomy Devices Market Drivers
  • 4.1.1. Rising prevalence of blood clots owing to cardiovascular diseases, neurological disorders, and trauma cases among others
  • 4.1.2. Growing geriatric population
  • 4.1.3. Rise in adoption of automated thrombectomy devices
• 4.2. Thrombectomy Devices Market Restraints and Challenges
  • 4.2.1. Device-related complications
  • 4.2.2. Stringent Regulatory Scenario
• 4.3. Thrombectomy Devices Market Opportunities
  • 4.3.1. Combined thrombolytic and mechanical approaches

5. Thrombectomy Devices Market Porter's Five Forces Analysis

• 5.1. Bargaining Power of Suppliers
• 5.2. Bargaining Power of Consumers
• 5.3. Threat of New Entrants
• 5.4. Threat of Substitutes
• 5.5. Competitive Rivalry

6. Thrombectomy Devices Market Layout

• 6.1. By Product
  • 6.1.1. Aspiration Thrombectomy Devices
  • 6.1.2. Mechanical Thrombectomy Devices
  • 6.1.3. Ultrasonic Thrombectomy Devices
  • 6.1.4. Others
• 6.2. By Applications
  • 6.2.1. Cardiovascular Thrombectomy
  • 6.2.2. Neurovascular Thrombectomy
  • 6.2.3. Peripheral Vascular Thrombectomy
• 6.3. By End-User
  • 6.3.1. Hospitals & Clinics
  • 6.3.2. Ambulatory Surgical Centers
  • 6.3.3. Others
• 6.4. By Geography
  • 6.4.1. North America
    • 6.4.1.1. United States Thrombectomy Devices Market Size in USD million (2021-2030)
    • 6.4.1.2. Canada Thrombectomy Devices Market Size in USD million (2021-2030)
    • 6.4.1.3. Mexico Thrombectomy Devices Market Size in USD million (2021-2030)
  • 6.4.2. Europe
    • 6.4.2.1. France Thrombectomy Devices Market Size in USD million (2021-2030)
    • 6.4.2.2. Germany Thrombectomy Devices Market Size in USD million (2021-2030)
    • 6.4.2.3. United Kingdom Thrombectomy Devices Market Size in USD million (2021-2030)
    • 6.4.2.4. Italy Thrombectomy Devices Market Size in USD million (2021-2030)
    • 6.4.2.5. Spain Thrombectomy Devices Market Size in USD million (2021-2030)
    • 6.4.2.6. Rest of Europe Thrombectomy Devices Market Size in USD million (2021-2030)
  • 6.4.3. Asia-Pacific
    • 6.4.3.1. China Thrombectomy Devices Market Size in USD million (2021-2030)
    • 6.4.3.2. Japan Thrombectomy Devices Market Size in USD million (2021-2030)
    • 6.4.3.3. India Thrombectomy Devices Market Size in USD million (2021-2030)
    • 6.4.3.4. Australia Thrombectomy Devices Market Size in USD million (2021-2030)
    • 6.4.3.5. South Korea Thrombectomy Devices Market Size in USD million (2021-2030)
    • 6.4.3.6. Rest of Asia-Pacific Thrombectomy Devices Market Size in USD million (2021-2030)
  • 6.4.4. Rest of the World (RoW)
    • 6.4.4.1. Middle East Thrombectomy Devices Market Size in USD million (2021-2030)
    • 6.4.4.2. Africa Thrombectomy Devices Market Size in USD million (2021-2030)
    • 6.4.4.3. South America Thrombectomy Devices Market Size in USD million (2021-2030)

7. Thrombectomy Devices Market Company and Product Profiles

• 7.1. Koninklijke Philips N.V.
  • 7.1.1. Company Overview
  • 7.1.2. Company Snapshot
  • 7.1.3. Financial Overview
  • 7.1.4. Product Listing
  • 7.1.5. Entropy
• 7.2. Terumo Corporation
  • 7.2.1. Company Overview
  • 7.2.2. Company Snapshot
  • 7.2.3. Financial Overview
  • 7.2.4. Product Listing
  • 7.2.5. Entropy
• 7.3. Medtronic
  • 7.3.1. Company Overview
  • 7.3.2. Company Snapshot
  • 7.3.3. Financial Overview
  • 7.3.4. Product Listing
  • 7.3.5. Entropy
• 7.4. Boston Scientific Corporation
  • 7.4.1. Company Overview
  • 7.4.2. Company Snapshot
  • 7.4.3. Financial Overview
  • 7.4.4. Product Listing
  • 7.4.5. Entropy
• 7.5. Penumbra, Inc.
  • 7.5.1. Company Overview
  • 7.5.2. Company Snapshot
  • 7.5.3. Financial Overview
  • 7.5.4. Product Listing
  • 7.5.5. Entropy
• 7.6. Thrombolex
  • 7.6.1. Company Overview
  • 7.6.2. Company Snapshot
  • 7.6.3. Financial Overview
  • 7.6.4. Product Listing
  • 7.6.5. Entropy
• 7.7. Imperative Care Inc.
  • 7.7.1. Company Overview
  • 7.7.2. Company Snapshot
  • 7.7.3. Financial Overview
  • 7.7.4. Product Listing
  • 7.7.5. Entropy
• 7.8. Stryker
  • 7.8.1. Company Overview
  • 7.8.2. Company Snapshot
  • 7.8.3. Financial Overview
  • 7.8.4. Product Listing
  • 7.8.5. Entropy
• 7.9. Argon Medical Devices Inc.
  • 7.9.1. Company Overview
  • 7.9.2. Company Snapshot
  • 7.9.3. Financial Overview
  • 7.9.4. Product Listing
  • 7.9.5. Entropy
• 7.10. Edwards Lifesciences Corporation
  • 7.10.1. Company Overview
  • 7.10.2. Company Snapshot
  • 7.10.3. Financial Overview
  • 7.10.4. Product Listing
  • 7.10.5. Entropy
• 7.11. Johnson & Johnson
  • 7.11.1. Company Overview
  • 7.11.2. Company Snapshot
  • 7.11.3. Financial Overview
  • 7.11.4. Product Listing
  • 7.11.5. Entropy
• 7.12. BD
  • 7.12.1. Company Overview
  • 7.12.2. Company Snapshot
  • 7.12.3. Financial Overview
  • 7.12.4. Product Listing
  • 7.12.5. Entropy
• 7.13. phenox GmbH
  • 7.13.1. Company Overview
  • 7.13.2. Company Snapshot
  • 7.13.3. Financial Overview
  • 7.13.4. Product Listing
  • 7.13.5. Entropy
• 7.14. DSMAREF CO.LTD
  • 7.14.1. Company Overview
  • 7.14.2. Company Snapshot
  • 7.14.3. Financial Overview
  • 7.14.4. Product Listing
  • 7.14.5. Entropy
• 7.15. Teleflex Incorporated
  • 7.15.1. Company Overview
  • 7.15.2. Company Snapshot
  • 7.15.3. Financial Overview
  • 7.15.4. Product Listing
  • 7.15.5. Entropy
• 7.16. AngioDynamics
  • 7.16.1. Company Overview
  • 7.16.2. Company Snapshot
  • 7.16.3. Financial Overview
  • 7.16.4. Product Listing
  • 7.16.5. Entropy
• 7.17. Abbott
  • 7.17.1. Company Overview
  • 7.17.2. Company Snapshot
  • 7.17.3. Financial Overview
  • 7.17.4. Product Listing
  • 7.17.5. Entropy
• 7.18. inari medical
  • 7.18.1. Company Overview
  • 7.18.2. Company Snapshot
  • 7.18.3. Financial Overview
  • 7.18.4. Product Listing
  • 7.18.5. Entropy
• 7.19. Merit Medical Systems
  • 7.19.1. Company Overview
  • 7.19.2. Company Snapshot
  • 7.19.3. Financial Overview
  • 7.19.4. Product Listing
  • 7.19.5. Entropy
• 7.20. Acandis GmbH
  • 7.20.1. Company Overview
  • 7.20.2. Company Snapshot
  • 7.20.3. Financial Overview
  • 7.20.4. Product Listing
  • 7.20.5. Entropy

8. KOL Views

9. Project Approach

10. DelveInsight Capabilities

11. About DelveInsight

12. Disclaimer & Contact Us